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Abstract
Background
Therapeutic hypothermia (TH) for 72h is the standard treatment following neonatal enceph-
alopathy (NE). However, one-third do not benefit and adjunctive therapies are urgently
needed. Xenon enhances neuroprotection with TH when administered at 50% concentration
within 5hours of hypoxia in experimental studies. Delayed initiation (~10 hours of age) of
30% xenon for 24 hours during TH did not improve early adverse biomarkers in a clinical
trial of Xenon+TH vs TH. After hypoxia-ischemia, excitotoxic injury via N-methyl-D-aspartate
receptor overactivation lasts days. Since xenon partially inhibits this receptor, we hypothe-
sised that giving 50% xenon throughout the entire 72h TH and rewarming periods would
enhance neuroprotection. Xenon costs $30/litre, so a closed-circuit breathing system is
desirable with automated fresh gas delivery.
Methods
Seven mechanically ventilated newborn pigs were randomized to receive 50% inhaled
xenon for 72h during hypothermia (rectal-temperature 35˚C) and subsequent rewarming fol-
lowing a global hypoxic-ischemic insult (XeHT, N = 4) or under normothermia for 72h (rec-
tal-temperature 38.5˚C) following sham insult (XeNT, N = 3). An automated fresh gas
delivery system injected oxygen/air/xenon boluses into a closed-circuit based on measured
gas concentrations.
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Results and discussion
Median (IQR) xenon consumption was 0.31 L/h (0.18, 0.50) and 0.34L/h (0.32, 0.49) for
hypothermic and normothermic groups respectively, 0.34L/h (0.25, 0.53) overall. 92% of
9626 xenon and 69% of 9635 oxygen measurements were within 20% variation from tar-
gets. For xenon concentration, the median absolute performance errors for the XeHT and
XeNT groups were 6.14% and 3.84% respectively and 4.31% overall. For oxygen these val-
ues were 13.42%, 15.05% and 12.4% respectively. There were no adverse pulmonary
pathophysiology findings. Clinical problems over the total period included three related to
sensors, seven breathing system leaks, ten partial and one complete tracheal tube occlu-
sion episodes.
Conclusion
The automated controller functioned as intended maintaining an inhaled xenon concentra-
tion close to the 50% target for 72-78h at a xenon cost of $11.1/h.
Introduction
Xenon, an anesthetic noble gas, is also a neuroprotectant reducing hypoxic brain injury follow-
ing birth asphyxia (hypoxic-ischemic encephalopathy, HIE) and stroke in newborn pre-clinical
models [1–5]. There is currently a large international clinical trial in progress investigating
neuroprotective effects of xenon in combination with cooling after cardiac arrest, based on a
favourable smaller trial [6–8]. It is also showing promise in pre-clinical in-vivo neuroprotec-
tion studies of other brain injury models such as sub-arachnoid haemorrhage and traumatic
brain injury [9–12]. Xenon may protect other organs such as the heart [13–15] and kidney
[16–18], and at present it is licensed for anesthesia in some European countries while these
other possible uses are the subject of ongoing medical research. The standard treatment for
HIE is therapeutic hypothermia (TH) i.e. cooling for 72hours (h), in order to reduce death or
disability [19]. Currently, despite TH, 11% of cooled infants still die and a further 22% of survi-
vors develop disability [20]. To improve the neurodevelopmental outcomes, xenon is being
investigated as a potential adjunct neuroprotective agent in clinical trials [21] Pre-clinical data
has indicated that xenon commenced within 5h of the hypoxic-ischemic insult at 50% concen-
tration enhanced hypothermic neuroprotection [2,3,22]. In the TOBY-Xe clinical trial, a com-
bination of xenon and whole body cooling did not alter early MRI biomarkers of adverse
neurodevelopment versus cooling alone. However, the concentration of xenon given at 33%
was lower than, and the time delay between birth and xenon delivery of approximately 10
hours was much greater than those used in most pre-clinical studies, so this finding is not
entirely unexpected [23]. In general, regardless of the neuroprotection modality being investi-
gated, it is highly desirable to have the shortest possible delay before treatment onset.
Following hypoxia-ischemia, glutamate accumulates in the synaptic cleft causing excessive
activation of the N-methyl-D-Aspartate (NMDA) receptor leading to excitotoxicity. The exci-
totoxic cascade of brain injury continues for days leading to long term disabilities [24]. As
xenon is an inhibitor of NMDA receptors at the glycine-co-agonist site, administering xenon
for the entire 72h duration of TH may reduce the excitotoxicity and enhance the neuroprotec-
tion [25,26]. In addition there are other molecular effects of xenon that may be involved in its
neuroprotective effect such as activation of two-pore-domain potassium channels TREK-1,
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inhibition of calcium adenosine triphosphate pump activity, antiapoptotic and stimulation of
norepinephrinergic neurons [27–29]. Xenon costs approximately $30/L, and so use of a circle
breathing system even with low fresh gas flows can still be very expensive over a long adminis-
tration period. However as tissue uptake of xenon via the lungs is extremely slow, a closed-cir-
cuit breathing system would be an ideal means to maximally exploit this property to minimise
fresh xenon requirements [29–33].
Delivering xenon for long periods via a closed-circuit breathing system under manual con-
trol has proved to be possible, however an automated breathing gas control system would be
more desirable [34]. It may also be desirable to supply this control system with fresh xenon at
ambient pressure, in order to largely eliminate the very high costs incurred when what would
normally be considered trivial leaks are present in systems supplied for long periods with pres-
surised gas. The neonatal pig model of global hypoxic-ischemic encephalopathy (HIE) simu-
lates the pathophysiology, brain and organ injury including lung dysfunction and injury of the
human condition [35,36] and has been used during the preclinical development of hypother-
mia as a neuroprotective intervention following NE.
Here, we developed an automated gas administration and control device with an ambient
pressure gas supply, for use with a single use closed circuit xenon breathing system. We evalu-
ated its ability to consistently maintain xenon at user-set target concentrations and investi-
gated the pulmonary effects including gas exchange and lung pathology of administering
xenon for 78h with 72h concurrent hypothermia and 72h without hypothermia in the new-
born pig global HIE model.
Materials and methods
These experiments were carried out under Home Office License (project license no: 3003332)
in accordance with UK guidelines and approved by the Animal Welfare Ethical Review Board
at the University of Bristol. This manuscript adheres to the applicable Equator guidelines.
To exploit the known low uptake of xenon via the lungs and the small size of neonates com-
pared to adults, a closed-circuit breathing system was used to minimise xenon consumption
[31]. This single-use circuit has been previously used by us in experimental and human neona-
tal clinical trials with manual addition of aliquots of fresh gas [34]. For this investigation an
automated gas controller was developed to monitor the recirculating breathing gas composi-
tion of this circuit and inject oxygen, air or xenon as required to bring the circulating gas mix-
ture towards user-set target values. Its main component parts were; sensors for measurement
of gas concentrations and airway pressure, actuators to deliver individual gases to the circle,
custom written control software running on a microcontroller (a small embedded computer),
and a user interface “Fig 1”.
Sensors and data collection
A conventional fuel cell oxygen analyser (AX300, Viamed Ltd., Keighley, UK) output the
measured oxygen fraction as a voltage with a range of 0 – 1V (0–100%) to the microcontroller
which converted this information into a digital form for further processing. Xenon has a
thermal conductivity markedly lower than that of other gases in the breathing system.
Xenon concentration was measured by a thermal conductivity analyser (GKM-03-INSOVT,
St. Petersburg, Russia. Obtained via Alfa-Impex Oy, Finland) with an RS232 serial data output
to the microcontroller. A pilot tube from the tracheal tube connector was connected to a pres-
sure transducer (MPXV7002DP, NXP Semiconductor, Austin Texas, US) which was continu-
ally monitored by the microcontroller, allowing detection of and differentiation between,
inspiratory and expiratory cycles as well as circuit disconnection.
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Fig 1. Diagram and corresponding image of apparatus. Upper: Combination of closed circle (left side) and
automated gas controller (right side). Oxygen driving gas from a conventional ventilator enters the lower chamber
during inspiration, compresses bag (A) causing gas to flow through soda-lime (B) in the upper chamber, down an
inspiratory hose to the lungs via a check valve (C). An oxygen substitution valve (D) permits oxygen to bypass into the
upper chamber in the event of any large leak or failure of the automated gas controller. There is also an overpressure
spill valve (E) for safety. The automated controller reads data from oxygen (F) and xenon (G) sensors and, during
expiration as detected via airway pressure changes, injects fresh gas boluses as required. In this example, linear actuator
(H) has drawn 18ml xenon from the xenon reservoir via unidirectional valve (I) into its small bellows and is injecting it
via unidirectional valve (J) into the expiratory limb (K). The inspiratory hose also contains a humidifier and heated
wire (not shown). Lower: Photograph of automated delivery system with labels corresponding to those of upper
diagram. Monitors and additional devices present are, from left to right; oxygen monitor, backup data printer, xenon
analyser with end-tidal carbon dioxide monitor mounted above it and a humidifier with heated wire in the inspiratory
hose.
https://doi.org/10.1371/journal.pone.0224447.g001
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Actuators
Three linear actuators (Universal heavy duty actuator, Candy Electronics Technology Co.,
Guangdong, China), were arranged so that under control of the microcontroller, they would
compress and then release, each of a set of three miniature silicone bellows (Pediatric test lung
bellows, Dra¨gerwerk, Lu¨beck, Germany) fitted with inlet and outlet unidirectional valves
(Infuvalve1, B Braun, Melsungen, Germany). Each therefore acted as a miniature gas pump
for xenon, oxygen or air, adding 18ml of gas to the breathing circuit each time the respective
actuator operated. An ambient pressure reservoir bag of oxygen and xenon was attached to
two of the bellows inlets while the third inlet was open to air via a filter, allowing it to draw in,
and inject, ambient air when required. This means of fresh gas supply had previously been
found to work with a manually controlled xenon delivery system in neonates [37]. The outlets
of these gas pumps entered the expiratory limb of the circle system, allowing fresh gases the
maximum opportunity to mix with breathing system gases before entering the lungs.
Microcontroller and control algorithm
The control algorithm is described “Fig 2”. After each fresh gas injection cycle, the controller
paused for a user-selectable time interval of 30, 50 or 70s to allow mixing of gases within the
circle, after which the means of 30 measurements of oxygen and xenon concentrations were
taken at 2s intervals to offset any residual unevenness of gas mixing around the circle. These
values were then compared with user-set target values for xenon and oxygen. Each gas injector
bellows would inject an 18ml bolus of gas when activated. In a manner similar to a chess com-
puter, the algorithm was programmed to predict the effect on the resulting combined gas con-
centrations of injecting all possible combinations of gas boluses (oxygen, xenon or air) up to a
total of 6 boluses per cycle, in any of 84 possible combinations. These calculations required an
estimate of overall system volume, a value reflecting not only the volume of the circle system
and lungs but also the effect of any other losses such as patient uptake (minimal) and leaks. It
would then select the combination that brought the predicted values closest to the user-set tar-
get values. The microcontroller continually monitored airway pressure which allowed it to act
as a disconnect alarm but also permitted it to only inject the selected combination of fresh gas
boluses during the expiratory cycle of ventilation. In any given cycle of measurement/calcula-
tion/gas injection, it would inject up to 6 boluses of fresh gas, in synchrony with expiratory
cycles of the mechanical ventilator. This was done to prevent injected gas boluses adding to the
set inspiratory tidal volume if a volume-controlled ventilation mode was in use. After waiting
for the set mixing time, the controller would measure another set of gas concentrations, com-
pare the previous prediction of gas concentrations against these new measured values and then
adjust the overall system volume value upwards or downwards by a fraction limited to ±10%
per cycle, accordingly. In this way its performance could gradually self-tune over time and also
compensate for situations such as very small leaks.
User interface
The controller unit had two 4-line back-lit liquid crystal displays. Although a long-established
technology, these are easy to read in any lighting conditions. During initial set-up a series of
menus was presented to the user allowing selection of the type of oxygen and xenon analysers
in use, the desired mixing time delay between cycles and target xenon and oxygen concentra-
tions, using a keypad. A toggle switch allowed the user to engage the automated controller or
pause it, for example while performing tracheal tube suction. While paused, any of the above
settings could be adjusted. When running, the controller displayed measured, predicted and
target concentrations for all three gases, while also showing a countdown timer until the next
Xenon delivery for 72h in neonatal piglets following hypoxic insult via a novel automated control system
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set of measurements, the estimated system volume variable and the pattern of gas boluses
selected by the algorithm in the previous cycle, e.g. 3 xenon, 2 oxygen, 1 air. Alarms were pro-
vided for circuit disconnection, high or low airway pressure, loss of signal from either gas ana-
lyzer and a low FiO2 from any cause. The estimated overall system volume variable, dependent
upon the concentration response to previous injections of xenon, functioned as small leak
indicator as in this event its value would increase above that typically expected.
Animal preparation
Crossbred Landrace/Large White newborn term pigs were housed in a pen with their compan-
ions before and in an intensive care facility during the experiment until perfusion/fixation. All
facilities were compliant with UK Home Office regulations as described previously [2]. In
brief, pigs after anaesthetic induction and intubation with a 3.0mm cuffed tracheal tube, were
ventilated using a neonatal ventilator (SLE 2000; SLE, Croydon, Surrey) with 1–2% isoflurane,
70% N2O and 28–29% O2 (humidified) before conversion to the xenon containing gas mix-
ture. 10% dextrose was administered at 60mls/kg/day. Oxygen saturation was measured and
Fig 2. Algorithm used by the automated controller for injection of boluses of fresh oxygen, air or xenon at
ambient pressure into the closed-circuit breathing system. � The microcontroller continually measured the airway
pressure in the background in order to firstly present an alarm if it fails to detect normal cycling of airway pressure and
secondly to allow injection of each bolus of fresh gas to be performed in synchrony with the expiratory cycle of
mechanical ventilation.
https://doi.org/10.1371/journal.pone.0224447.g002
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also end-tidal CO2 via a mainstream capnograph to prevent xenon removal via any gas sam-
pling line (VM-2500-M Mainstream Capnograph, Viamed Ltd., Keighley, UK). Oxygen satu-
ration and end-tidal CO2 was maintained between 92–95% and 4.5–5.5kPa respectively. A
commercial temperature control system pumped water at a variable temperature through a
wrap enveloping the pigs to maintain their core temperature at a user set value (Criticool,
MTRE, Yavne).
Experiment protocol
After animal preparation (n = 7), four anesthetized and ventilated newborn pigs were rando-
mised to receive 50% inhaled Xe via an automated delivery system for 78h during hypothermia
and rewarming (rectal temperature, Trectal 35˚C for 72h followed by rewarming) following a
global hypoxic-ischemic insult (XeHT, N = 4) and three were randomised to receive xenon
during normothermia (for pigs) for 72h (Trectal 38.5˚C) following a sham insult (XeNT, N = 3),
with background propofol and fentanyl infusions. The hypoxic-ischemic insult was applied
according to an established described technique; after checking the tracheal tube cuff for an
absence of leaks, the inspired oxygen fraction was reduced to between 3 and 7% to depress the
background aEEG amplitude to below 7 μV for 45 minutes [30].
The automated gas control system and closed circuit was used to maintain target xenon
and oxygen concentrations for this entire period. Manual partial flushes of the breathing sys-
tem with fresh gas were carried out at intervals of 8h.
After the end of intervention, pigs were extubated once they were able to breathe spontane-
ously. After a further 12h normothermic survival, pigs underwent perfusion fixation of brain
under deep anaesthesia. We conducted autopsy and removed the lungs, which were fixed in
4% formaldehyde. Two sections from the three lobes of the right lung and two lobes of the left
lung were stained with haematoxylin and eosin and, and the elastic fibres were stained with
Verhoeff’s Van Gieson stain [38]. Two slides from each lobe of the lung (right lung: 3 lobes
and left lung: 2 lobes) were scored qualitatively for the presence of histological abnormalities,
intra-alveolar fibrin, hyaline membranes, inflammation and oedema. The pathologist who was
blinded to the intervention received by the piglets categorically scored the presence of these
abnormalities as yes (1) or no (0).
Statistical analysis
We utilised the pooled-data approach to assess the performance of the system [39,40].
Percentage performance error. Percentage performance error (PPE) was defined as the
percentage difference between each measured gas concentration in the breathing system and
the target value for that gas. The PPE for the ith piglet at the jth measured value versus the set
target value at that time was calculated as follows:
PPEij ¼
ðmeasured gas concentrationij   target gas concentrationjÞ
target gas concentrationi
X 100
Median absolute performance error. Median absolute performance error (MDAPE) is a
measure of inaccuracy and indicates the absolute magnitudes of the differences between mea-
sured and target gas concentrations.
MDAPEi = median{|PPEij|, j = 1,. . .. . .,Ni}
MDAPE ¼
1
PM
i¼1 Ni
�
PM
i¼1ðN
x
i MDAPEiÞ
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with Ni being the number of values of |PPE| for the ith piglet and M being the number of pig-
lets in the study.
Median performance error. Median performance error (MDPE) is a measure of bias and
indicates whether the differences between measured gas concentrations were systematically
above or below the target gas concentrations.
MDPEi = median{PPEijj = 1,. . .. . ..,Ni}
MDPE ¼
1
PM
i¼1 Ni
�
PM
i¼1ðN
x
i MDPEiÞ
Wobble. Wobble measures how much PPE fluctuates around the MDPE with time, for
each piglet (i.e. intrasubject PPE variability).
WOBBLEi = median {|PPEij−MDPEi|,j = 1,. . .. . ..,Ni}
WOBBLE ¼
1
PM
i¼1 Ni
�
PM
i¼1ðN
x
i WOBBLEiÞ
All calculations were performed using Microsoft Office Excel, 2016, version 1803 (Micro-
soft Corporation, Redmond, WA, USA).
Results
The piglets (n = 7) had a median (IQR) weight of 1.53 kg (1.41, 2.09), with a median (IQR) age
of 14.0 hours (9.3, 19.5) from birth. 57% were males. During the automated control of breath-
ing, we acquired a total of 9626 xenon and 9635 oxygen artefact free concentration measure-
ments over a median (IQR) total running period of 68.6 hours (67.1, 70.7). The median (IQR)
hourly Xe consumption in the XeHT group was 0.31 L/h (0.18, 0.50) and in the XeNT group
was 0.34L/h (0.32, 0.49) (Fig 3) and the overall consumption was 0.34L/h (0.25, 0.53). The
maximum and minimum total xenon consumption over 72 hours for the seven pigs were 53.5
L and 9.3 L. The slopes of xenon consumption in the XeHT pigs were 7.435, 1.358, 6.334 and
2.382, whilst the slopes in the XeNT group were 1.539, 2.977 and 3.135. The concentrations of
xenon and oxygen in the breathing gas mixtures are also shown in (Fig 3). 92% of 9626 xenon
measurements and 69% of 9635 oxygen measurements were within 20% variation from target
values respectively. Among the 7 pigs, 5 reached the target xenon concentration of 50% within
50 mins, 1 pig reached target by 60 min and the other pig reached target by 100mins. Mean
(SD) xenon concentration during the 72hour cooling period was 49.6% (4.52) and the mean
(SD) oxygen concentration during the 72-hour cooling period was 28.9% (5.06). (Fig 3) Dur-
ing rewarming, the mean (SD) xenon concentration was 48% (3.53) and the mean (SD) oxygen
concentration was 33.7% (8.1). In the final hour of rewarming, xenon concentration was
reduced to a mean (SD) of 37.3% (26), whilst maintaining a mean(SD) oxygen concentration
of 31.8% (9.75). (Fig 3)
With regard to the performance of the system, the absolute performance error and wobble
are described in (Fig 4). Median (IQR) of absolute performance error for xenon concentration
in the XeHT group were 3.7 (1.56, 6.98), 4.2 (1.56, 7.62), 14.1 (9.91, 17.75) and 2.4 (0.96, 6.55)
and in the XeNT group were 5.5 (2.69, 9.23), 2.7 (1.15, 5.47) and 3.3 (1.48, 7.69). The distribu-
tion of outliers in the absolute performance error for xenon concentration were similar
between the XeHT and the XeNT group with maximum values of 58.6, 91.1, 63.4 and 67.7 in
the XeHT group and 58.1, 66.2 and 54.5 in the XeNT group. (Fig 4) Median (IQR) of absolute
performance error for oxygen concentration in the XeHT group were 10 (5.33, 15.83), 29.6
(21.36, 53.2), 5.3 (2.5, 8.92) and 9.58 (6.66, 13.33) and in the XeNT group were 16.5 (8.4,
Xenon delivery for 72h in neonatal piglets following hypoxic insult via a novel automated control system
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29.13), 12.2 (6.15, 20.38) and 16.4 (8.8, 26). The distribution of outliers of absolute perfor-
mance error for oxygen concentration were similar between the XeHT and the XeNT groups
with maximum values of 176.8, 175.2, 167.8, 144.5 in the XeHT group and 194.8, 189.2 and
150 in the XeNT group. “Fig 4” Median (IQR) wobble for xenon concentration in the XeHT
group were 3.8 (1.76, 6.47), 3.2 (1.5, 5.6), 3.8(1.55, 7.58) and 2.1 (0.96, 6.15) and in the XeNT
group were 5.5 (2.69, 9.61), 2.5 (1.09, 5.19) and 3.5 (1.34, 6.34). The outliers for the wobble
were similarly distributed between the XeHT and the XeNT group with maximum values of
56.8, 87.1, 49.3 and 66.0 in the XeHT group and 55.1, 64.4 and 56.4 in the XeNT group. “Fig 4”
Median (IQR) wobble for oxygen concentration in the XeHT group were 9.3 (4.58,14.64), 10.8
(5.6, 27.6), 5.3 (2.49, 9.28) and 3.3 (1.57, 6.66) and in the XeNT were 13.3 (6.31, 22.49), 9.2 (3.7,
16.37) and 9.6 (4.4, 17.2). The distribution of outliers was similar between the XeHT and the
XeNT group with a maximum wobble of 181.8, 146, 168.5 and 135.4 in the XeHT group and
180.3, 178.8 and 134 in the XeNT group. The pooled estimates of xenon concentrations for
MDAPE, MDPE and Wobble for the XeHT group were 6.14, -5.47 and 3.21 and for the XeNT
group were 3.84, -2.24 and 3.86 with values for both groups combined of 4.31, -3.26 and 3.42
respectively. The pooled estimates of oxygen concentrations for MDAPE, MDPE and Wobble
for the XeHT group were 13.42, 8.36 and 6.98 and for the XeNT group were 15.05, 13.64 and
10.7 with values for both groups combined of 12.4, 9.62 and 7.86 respectively.
As expected, when ventilating animals approximately half the weight of a term human neo-
nate, with cuffed tracheal tubes, for such an extended period, via a closed-circuit breathing sys-
tem, there were a number of practical clinical problems requiring intervention. Although not
necessarily directly related to the electronic control system, for example the development of a
Fig 3. Mean (SEM) xenon and oxygen concentrations with cumulative xenon consumption shown above on same
time scale. On xenon consumption chart: Green lines represent Normothermia animals while Blue lines represent
Hypothermia (72h) followed by rewarming. In one case�, the xenon consumption rate can be seen to suddenly
increase due to the presence of a leak, which was compensated for by the gas controller. One xenon-hypothermia
experiment was stopped early, as the animal underwent terminal perfusion fixation due to refractory hypotension. In
the xenon oxygen concentration graph, green circles denote xenon concentration and red circles denote oxygen
concentration.
https://doi.org/10.1371/journal.pone.0224447.g003
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small breathing system leak, the controller would then automatically try to compensate for
such anomalies so affecting its overall performance, creating variability between animals in the
overall xenon consumption. These events are summarised in (Table 1).
The transcutaneous oxygen saturation remained stable during the xenon administration
period “Fig 5”. The saturation data is presented for every minute in “Fig 5”. Only 0.5% of the
measurements were< 80% and 0.1% were < 70%. Arterial partial pressure of CO2 reduced
from a median (IQR) of 41.7mmHg (36.4, 47.6) before hypoxic-ischemic insult to 29.3mmHg
(25.7, 35.6) at the end of hypoxic ischaemic insult. The PCO2 was maintained higher during
the cooling period in the XeHT group at a median (IQR) of 45.3mmHg (33.9, 53.1) than dur-
ing the normothermia period in the XeNT group 38.2 mmHg (33.1, 40.6) to account for the
PCO2 lowering effect of hypothermia “Fig 6”.
Fig 4. Xenon and oxygen control parameters. A) Boxplot Absolute PPE Xenon. Represents absolute magnitude of the differences between measured and
target gas concentrations. B) BoxplotWobble for Xenon. Represents the fluctuation in percentage performance error around the median performance error
(MDPE) for each subject. C) Boxplot Absolute PPE Oxygen. Represents absolute magnitude of the differences between measured and target gas
concentrations. D) Boxplot Wobble for Oxygen. Represents the fluctuation in percentage performance error around the median performance error (MDPE)
for each subject. Box plot represents the minimum, interquartile range, median and the maximum values. The outliers are shown as blue filled circles for the
XeHT group and green filled circles for the XeNT group.
https://doi.org/10.1371/journal.pone.0224447.g004
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With respect to lung pathology, there were no macroscopic injury noted during the
autopsy. There were no histologic features indicating lung injury in the right upper, middle
and lower lobes and in the left upper and lower lobes “Fig 7”. None of the animals had intra-
alveolar fibrin, hyaline membranes, inflammation and oedema. There was no evidence of atel-
ectasis. Eosin and haematoxylin stained sections from three different animals are shown in
“Fig 8”.
Table 1. Summary of main clinical problems encountered classified by type.
Event Type Frequency
Oxygen sensor failure. 3
Failure of sensor communication with gas controller. 2
Oscillation of FiO2 below 0.21 where this was due to the target mean FiO2 being set too low. 8
Tracheal tube partial occlusion with secretions. 10
Complete tracheal tube occlusion requiring replacement. 1
Small breathing system leak 5�
Large breathing system leak requiring complete breathing system replacement. 2
Low FiO2 due to empty oxygen reservoir bag. 1
(� In two of these instances the controller compensated for the gas leak and the situation was monitored by the
operator who did not need to manually intervene. In the remainder the leak was physically corrected by the
operator).
https://doi.org/10.1371/journal.pone.0224447.t001
Fig 5. Transcutaneous oxygen saturation. Median and 25th percentile data of transcutaneous oxygen saturation every minute against time.
Green colour represents XeNT group and blue colour represents the XeHT group. The error bars are the 25th percentile.
https://doi.org/10.1371/journal.pone.0224447.g005
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Discussion
The majority of measured xenon concentrations fell within 20% variation of the set target
value; 8830 out of 9626 total measurements (92%). The majority of measured oxygen concen-
trations fell within 20% variation of the set target value; 6630 out of 9635 total measurements
(69%).
We evaluated the control system performance using previously described methods used to
evaluate other closed loop control systems [39,40]. We analysed the performance of the control
system with respect to the period of xenon/oxygen delivery in each individual animal and then
also the overall performance with respect to the pooled data from all the animals. The pooled
data analysis gives a weight to each measurement according to the total number of measure-
ments obtained for each of the seven animals. We did this because averaging the measure-
ments would underemphasise data from piglets with fewer xenon and oxygen measurements
while overemphasising the data from the others with a larger number of gas concentration
measurements. In each of the seven animals, we delivered xenon for three days to replicate the
clinical scenario where xenon might be applied for the entire cooling period currently recom-
mended for clinical use. From the perspective of the gas delivery and control system evalua-
tion, this therefore represented 21 days of use which we regarded as sufficient for an initial
technical evaluation.
The negative MDPE, a measure of bias, shows that overall, the xenon concentration was
maintained slightly below target levels by a median of 3.3% while the oxygen concentration
was maintained slightly above the target values by a median of 9.6%. The MDAPE variable
Fig 6. Arterial partial pressure of carbon dioxide (PCO2)Median (IQR) of PCO2 against time. Surgery end and Pre insult indicates the
baseline values. The hypoxic-ischemic insult lasted for 45 mins including the time points 15min 30min and 45 min. Blue circle indicates the
XeHT group and the green triangle represents XeNT group.
https://doi.org/10.1371/journal.pone.0224447.g006
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reveals that our system resulted in xenon concentration values that differed from target by a
median of 4.3% (of the target value) while with respect to oxygen concentrations the median
value was 12.4%. This reflects the accuracy of the system with respect to the set target gas con-
centration for each gas. The outliers in the absolute performance error and wobble capture the
incidents indicated in Table 1 and the 8 hourly manual partial flushes of the system, during
which the measured gas concentrations come down significantly followed by achieving the tar-
get concentration with time.
None of the pigs showed any evidence of injury to the lung parenchyma or lung vasculature.
This is reassuring as despite administration of xenon, a gas with a density 4.5 times that of air,
Fig 7. Lung histology scoring from the right and left lung. Lung histopathology scoring includes: no histological abnormalities (0), intraalveolar
fibrin (1), hyaline membranes (2), inflammation (3) and oedema (4). Lung lobes are represented as, R upper: Right upper lobe; R middle: Right
middle lobe; R lower: Right lower lobe; L upper: Left upper lobe; L lower: Left lower lobe. Blue filled circles represent the XeHT group and the green
filled circles represent the XeNT group.
https://doi.org/10.1371/journal.pone.0224447.g007
Fig 8. Lung histology indicating no evidence of injury. A] haematoxylin & eosin stained low power microscopic section (� hyaline cartilage plate) B] haematoxylin &
eosin stained section showing normal alveolar architecture with no evidence of interstitial oedema, fibrosis, haemorrhage or haemosiderin-laden macrophages and C]
Verhoeff’s Van Gieson stained section for elastic fibres. The vasculature showed normal appearances.
https://doi.org/10.1371/journal.pone.0224447.g008
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for long periods there was no microscopic evidence of lung injury. The lung sections from
each lobe were qualitatively assessed by a pathologist who was blinded to the intervention.
Although, a quantitative assessment was not conducted, we are confident that the qualitative
technique which is used in clinical practice will pick up any clinically significant injury to the
lungs.
Transcutaneous oxygen saturation was recorded every minute. A clinically significant desa-
turation occurred in 0.1% of these. Some of these desaturations coincided with the endotra-
cheal tube occlusion episodes and other practical problems requiring clinical intervention
described in Table 1. Furthermore, the quality of pulse waveform during these low values were
unable to be checked offline and movement artefact affecting the values could also not be
excluded. This low level of clinically significant desaturation is comparable to those seen in
intensive care settings, where appropriate interventions would be instituted as had happened
in our experiments and so long as they are recognised and dealt with promptly, they would be
unlikely to impact the brain recovery.
There were a number of technical challenges in this investigation. Since the set target value
for xenon was typically twice the set target value for oxygen then any given numerical devia-
tion in the measured fraction of each gas in the breathing system from target value will appear
to be greater when expressed as a percentage of the target value with respect to oxygen than it
would with respect to xenon. It is technically easier to accurately control the concentration of
xenon in a binary xenon/oxygen mixture where xenon comprises approximately half the gas in
the system, with the balance simply being made up of oxygen. However, in neonates with HIE
who are at risk of worsening the brain injury due to even mild hyperoxia, it is considered
undesirable to deliver an oxygen fraction higher than absolutely necessary. This becomes chal-
lenging if the user set target oxygen fraction approaches 0.21 as with any automated control
system, the measured concentration will vary not only slightly above, but also slightly below,
the target value over time. Setting the FiO2 to a default target of 0.33 for example to allow for
such variations would not always be clinically acceptable post-hypoxia in neonates. In contrast,
with respect to xenon and a typical set target of 0.5, such a variation would be clinically less
important. A further challenge for this experiment was that the controller had to simulta-
neously control the concentration of xenon, representing approximately half of the gas in the
system, as well as that of oxygen, representing approximately a quarter of the gas in the system,
and nitrogen as the balance gas, complicated by the fact that injection of any one gas under
computer control would dilute the concentration of the others present.
It can be seen that the automated control system performed better than these pooled values
when data from individual runs are examined. Those with the lowest overall xenon consump-
tion tended to be the piglets where there were fewer technical clinical problems over the 72h
period that needed manual intervention, for example breathing system leaks which the con-
troller was then trying to compensate for and tracheal tube partial occlusion with underventi-
lation, among others. This suggests that the overall performance of the controller system
might be improved if the incidence of technical and clinical problems not directly due to the
controller algorithm itself could be reduced as clinical experience developed.
For example, with respect to two of the incidents summarised as part of Table 1, Pig 3 expe-
rienced several periods of ventilation difficulty, even after the tracheal tube had been replaced,
requiring multiple episodes of suction and lavage via the tracheal tube. During this period this
would have negatively impacted upon the ability of the gas controller to accurately control the
breathing gas mixture as a normal tidal volume is desirable to circulate and evenly mix any
injected fresh gases before an updated measurement of the gas concentrations is made by the
sensors.
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The small tidal volume and reduced respiratory rate requirements of piglets weighing
1.53kg i.e. half that of a human neonate, once cooled, would reduce the rapidity of even gas
mixing through the circle after each fresh gas injection. Although ameliorated by using the
mean of multiple gas concentration measurements separated in time, it might be expected that
in larger human neonates this possible source of error would be reduced.
In the best experiment (Piglet 1) the xenon consumption was only 0.15Liters ($ 4.5) per
hour and in this case it was notable that there were also the least number of clinical and techni-
cal problems. This example perhaps suggests what might be achievable with further technical
development and also practical clinical experience.
Conclusions
In conclusion we have demonstrated that using an automated closed-circuit xenon delivery
system, it is feasible to administer xenon consistently at a pre-determined therapeutic concen-
tration for 72 to 78 hours in conjunction with hypothermia at a potentially low cost without
inducing lung injury. The challenges faced in the study were largely unrelated to the system
design suggesting that with further development an automated control system could have a
place where xenon is delivered for long periods in human neonatal research trials.
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